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Gastric Leptin is absorbed by duodenal enterocytes and released on the basolateral side towards the bloodstream. We investigated
in vitro some of the mechanisms of this transport. Caco-2/15 cells internalize leptin from the apical medium and release it through
transcytosis in the basal medium in a time- temperature-dependent and saturable fashion. Leptin receptors are revealed on the
apical brush-border membrane of the Caco-2 cells. RNA-mediated silencing of the receptor led to decreases in the uptake and
basolateral release. Leptin in the basal medium was found bound to the soluble form of its receptor. An inhibitor of clathrin-
dependent endocytosis (chlorpromazine) decreased leptin uptake. Confocal immunocytochemistry and the use of brefeldin A and
okadaic acid revealed the passage of leptin through the Golgi apparatus. We propose that leptin transcytosis by intestinal cells
depends on its receptor, on clathrin-coated vesicles and transits through the Golgi apparatus.
1.Introduction
Endocrine leptin is mainly produced by the white adipose
tissue [1] and its primary function consists in the long-term
control of food intake and energy storage [2, 3]. It is also
involved in various other physiological processes, including
reproduction, immunity, and cell growth [4–6]. Aside from
adipocytes, epithelial chief cells of the gastric mucosa were
f o u n dt ob eam a j o rs o u r c eo fl e p t i n[ 7, 8] and this secretion
has been established to be exocrine being discharged into the
gastric lumen to the gastric juice [7, 8].
Gastric chief cells synthesize and store leptin in their
secretory granules which also contain pepsinogen [8]. To
ensure its integrity in the proteolytic environment of the
digestive tract, gastric leptin is secreted complexed to a
protective binding protein that results from the cleavage of
membrane-bound leptin receptor [9]. The cleavage of the
membrane bound receptor generates the soluble isoform
of this receptor. The complex leptin-soluble receptor is
formed in the secretory granules of the chief cells and upon
stimulation released into the gastric juice [9]. It is then
channelled to the duodenal lumen [9].
At the level of the duodenal enterocyte apical mem-
brane, leptin binds to its membrane-bound receptor trig-
gering some signalling cascades [10, 11]. In human, three
membrane-bound receptors have been cloned and identiﬁed
as 219.1 (long isoform), 219.2, and 219.3 (short isoforms)
[12]. Their extracellular and transmembrane domains are
identical, with an intracellular domain varying in size
and aminoacid sequence, suggesting that each membrane-
bound receptor activates diﬀerent intracellular pathways and
possesses speciﬁc roles [12, 13]. They control, amongst other
processes, nutrient absorption and mucus secretion [10, 11,
14]. The particular leptin soluble receptor that is generated
by the proteolytic cleavage of the extracellular domain of
membrane-bound ones [9] protects leptin, and increases its
half-life [9].
Interestingly,membrane-boundandsolubleleptinrecep-
tors share a similar structure, have the same aﬃnity for
leptin and their competition modulates leptin action on2 International Journal of Cell Biology
the intestinal wall [15]. Finally, upon internalization by
the duodenal epithelial cells, leptin is transcytosed through
the cells and released on the basolateral side to reach the
blood stream in an intact form [16]. A similar transport of
macromolecules across the intestinal epithelial cells has been
previously reported for several other proteins [17–19].
Molecular events taking place for duodenal leptin trans-
port have not been established. We have therefore under-
taken the present study to characterize some aspects of the
leptin intestinal transcytosis. Using human intestinal Caco
2/15 cells, we demonstrate that this transport across the cells
isdependentuponthelongisoformoftheleptinreceptor.We
also show that as for other cell types the endocytotic process
seems to be clathrin-dependent. In addition, our ﬁndings
emphasize the role of the Golgi apparatus in the intracellular
leptin traﬃcking and reveal that leptin released into the basal
medium is bound to its protective soluble receptor.
2.MaterialandMethods
2.1. Antibodies and Chemicals. Rabbit antibodies against
human leptin (A20) and human leptin receptor (H300)
were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). Monoclonal mouse antiβ-actin (clone AC15),
ﬂuorescein isothiocyanate (FITC), and albumin were from
Sigma-Aldricht (St-Louis, MO, USA). Monoclonal mouse
antiTNG38/42 (MA3-063) was obtained from ABR (Cedar-
lane Laboratories, Hornby, Ont.). Secondary antibodies
with ﬂuorescent tags Alexa 488 and Alexa 568 were from
by Invitrogen (Burlington, ON, Canada). The secondary
antibodies antirabbit/mouse for Western blot were part of
the detection kit from Roche Diagnostics (Indianapolis, IN).
Protein-A-HRP (Horse Radish Peroxidase) was from GE
Healthcare limited (Amersham, UK). Human recombinant
leptin was purchased from R&D systems (Minneapolis,
MN). Recombinant insulin was from Eli Lilly (Toronto, On,
Canada).
2.2. Synthesis of Leptin-FITC. FITC (50μg) and human
recombinant leptin (1mg) were solubilized in 300μLo f
NaHCO3 buﬀer (50mM; pH 9) and left overnight at 4◦C
with agitation, as previously reported [16]. The following
morning, dialysis was performed in PBS (pH 7.4) for 24
h o u r st or e m o v ef r e en o n b o u n dF I T C .T h eﬁ n a lc o n c e n t r a -
tion of Leptin-FITC in PBS was brought to lmg/mL.
2.3. Cell Culture. The human intestinal Caco-2/15 line was a
generous gift from Dr Jean-Franc ¸ois Beaulieu (Sherbrooke
University, QC, Canada). Cells were maintained at 37
◦C
under a 95% air and 5% CO2 atmosphere in a culture
medium of the following composition: minimum essen-
tial medium (EMEM; Wisent, St-Bruno, QC, Can), peni-
cillin/streptomycin (100kU/L), MEM nonessential amino
acids (0.1mmol/L)(Gibco, Invitrogen, Auckland, NZ, USA),
and foetal bovine serum 5% ﬁnal (FBS; Flow, McLean, VA).
Cells were grown in 75cm2 ﬂasks (Corning, NY, USA)
until 70–80% conﬂuence. Cell layers were then washed
twice with PBS and detached using trypsin-EDTA (50g/L-
0.5mmol/L; Gibco-BRL). After cell counting, 6-well plates
with 24.5mm polycarbonate Transwell ﬁlter (pore size
0.4μm) (Coastar, Cambridge, MA) were seeded at a density
of 1×106 cells/well. Cells were kept for 21 days postconﬂu-
ency to ensure full diﬀerentiation and polarization, leading
to a tight monolayer and allowing complete segregation
between the upper and lower compartments of the wells.
Prior to each experiment, cells were cultured in an FBS-
free medium for 20 hours and electric resistance of each
w e l lw a sm e a s u r e dt oc o n ﬁ r mc e l lc o n ﬂ u e n c ya n dj u n c t i o n a l
tightness. At the end of the transcytosis experiment, leptin-
FITC adsorbed on cell plasma membranes was removed
by addition v/v of acetic acid (0.5M)/NaCl (0.5M) on
both apical and basal mediums, followed by thorough PBS
washings prior to cell homogeneization [20].
2.4. Small Interfering RNA. Plasmid plKO.1 was obtained
from Invitrogen (Carlsbad, CA). Mission TRC shRNA
target set for leptin receptor short and long isoforms
was purchased from Sigma-Aldricht (St-Louis, MO, USA).
Structures of the shRNA hairpins are as follows: CCGGGC-
CTATGAGCAAAGTAAATATCTCGAGATATTTACTTT-
GCTCATAGGCTTTTTG,CCGGCCAGTGTGAAAGAG-
AAATTACTCGAGTAATTTCTGCTTTCACACTGGTTT-
TTG,CCGGGCAAGATAGAAACTGCTCCTTCTCGAG-
AAGGAGCAGTTTCTATCTTGCTTTTTG, CCGGCGT-
GTCTTTACCACACAAGATCTCGAGATCTTGTGTGGT-
AAAGACACGTTTTTG,CCGGCCTGGGCACAAGGAC-
TTAATTCTCGAGAATTAAGTCCTTGTGCCCAGGTTT-
TTG. Plasmid and insert sizes were conﬁrmed by enzymatic
digestion. Each hairpin for leptin receptor cDNA has the
following structure: BamH1 site, a 21-nucleotide sense
sequence, a spacer (CTCGAG), a 21-nucleotide antisense
sequence, stop signal for RNA polymerase III (TTTTT) and
Nde1 site. Two plasmids referred to constructs C7 and C9
were used for the invalidation procedure.
2.5. Lentiviral Infection. Lentiviruses were produced by
cotransfecting293Tcellswithpackagingplasmidsplp1(5μg,
gag/pol), plp2 (5μg, rev), VSV-G (5μg, envelope), and the
s h R N Ap l a s m i dC 7o rC 9( 5 μg, leptin receptor) or GFP
(5μg, control of successful infection). Brieﬂy, all plasmids
were mixed together in a CaCl2 Hepes buﬀer and added to
cell culture medium. Following a 4-hour incubation at 37
◦C,
the medium was removed and replaced with a fresh one
containing 10% FBS. After 2 days, supernatants containing
the viruses were taken, ﬁltered through a 0.45μm ﬁlter,
and frozen at −80
◦C until use. Viral infection was carried
out for 72 hours on 2×105 Caco-2/15 cells. They were
then trypsinated and grown in T75 ﬂasks with 10μg/mL
puromycin or blasticidin 2μg/mL as selection agents for
shRNA and GFP plasmids, respectively.
2.6. RT-PCR. RNA was extracted with Trizol buﬀer (Invit-
rogen, Carlsbad, CA, USA) as previously reported [21].
After measurement of RNA concentration at 260/280nm,
reverse transcription was carried out on 5μgo fR N AInternational Journal of Cell Biology 3
using a kit from Invitrogen. PCR was performed using
Fermentas kits (Burlington, On, Can) and a Biometra
cycler (Montreal Biotech Inc Kirkland Canada). Primers
for human leptin receptor and reference gene GAPDH
mRNAs had the following sequence: 219.1 forward TTG-
GAAGCCCCTGATGAAA, 219.1 reverse AGCAGATAA-
ACAAGTGAACAAAG, 219.2 forward TTGGAAGCCCCT-
GATGAAA, 219.2 reverse AGGTGCGCACGAGGTAGGA,
219.3 forward ATTCAATTGGTGCTTCTGTT, 219.3 reverse
CATTGGGTTCATCTGTAGTG, GAPDH forward AGA-
AGGCTGGGGCTC, GAPDH reverse GGGCCATCCACA-
GTC. DNA was ampliﬁed as follows: denaturation at 95
◦C
for 30 seconds, annealing at 52
◦C for 30 seconds, and
elongation at 72
◦C for 30 seconds. For each set of primers,
a saturation curve was realized to determine the linear
portion of the exponential phase that was found between
28–39 cycles. Final elongation lasted 10 minutes at 72
◦C. All
samples received loading buﬀer and were resolved on a 1%
agarose gel with ethidium bromide (1ng/mL ﬁnal).
2.7.WesternBlot. Cellswerehomogenizedinlysisbuﬀer(M-
Per, Thermo Scientiﬁc, Rockford, IL, USA) containing a mix
of proteases inhibitors (PMSF, pepstatin, BHT, leupeptin),
sonicated and stored at −80
◦C until use. Protein concen-
trations were measured using a Biorad kit (Hercules, CA,
USA). For immunoblots, samples were heated at 95
◦Ci n
Laemmlibuﬀerfor5minutesthenresolvedona7.5%or10%
SDS-PAGE gel. Proteins were transferred onto nitrocellulose
membranes in the presence of methanol. Nonspeciﬁc bind-
ing sites were saturated for 1 hour in TBS containing tween
(0.1%)andmilk(1%).Membraneswereincubatedovernight
at 4◦C with primary antibodies (antileptin 1/2000, antileptin
receptor 1/3000, antiFITC 1/2000, antiβ-actin 1/20000). The
following day, signals were revealed using secondary anti-
bodies bound to HRP (1/10000) and a chemoluminescent
reagent (Roche Diagnostics, Indianapolis, IN).
2.8. Confocal Microscopy. Caco-2/15 cells were grown on
glass cover slides coated with 0.1% gelatine. Upon exposure
toleptinfor45minutesandwashing,cellswereﬁxedwith4%
paraformaldehyde for 20 minutes, they were permeabilized
with Triton ×100 (0.1% in PBS) for 3 minutes and washed
three times with a solution of glycine (5mM in PBS). Cells
were then incubated for 1 hour with foetal bovine serum
(FBS 10% in PBS). Incubation with the primary antibody in
FBS 10% was carried out overnight at 4◦C (antiFITC 1/250,
antiTGN42 1/250). The following morning, the secondary
antibody was added (Alexa 488 1/500 and Alexa 568 1/500)
for 30 minutes, and upon thorough washing the cells were
mounted in DABCO/glycerol (v : v 5/50%) in PBS. Negative
controls were incubated with FBS 10% alone followed by
the secondary antibody in the same conditions. Slides were
analyzed with a confocal microscope (Quorum WaveFX
Spinning Disc in CSU10 confocal scanner unit Yokogawa
m o u n t e do na nO l ym p u sB X 6 1 W I )f r o mQ u o r u mt e c h n o l o -
gies Inc (Ghelph, On, Canada) and images processed with
Volocity software (Improvision Ltd, Waltham, MA, USA).
Quantiﬁcation of the staining was carried out using UN-
SCAN-IT gel 6.1 software (Silk Scientiﬁc Corporation).
2.9. Electron Microscopy. C a c o - 2 / 1 5c e l lc u l t u r e sw e r eﬁ x e d
in 1% (v/v) glutaraldehyde in 0.1M sodium phosphate
buﬀer, pH 7.4, for 2 hours at 4◦C. They were then
washed with phosphate buﬀer, dehydrated in a series of
graded methanol solutions at decreasing temperature (until
reaching −30
◦C), and embedded in Epon or Lowicryl
(K4M CANEMCO; St-Laurent, Canada) as reported pre-
viously [22, 23]. Semithin sections were observed by light
microscopy. Thin sections of the lowicryl-embedded mate-
rial were mounted on Parlodion and carbon-coated nickel
grids and processed for the immunogold labeling [22, 23].
Quenching of nonspeciﬁc binding sites was carried out with
glycine (0.15mM in PBS, pH 7.4) at room temperature,
followed by ovalbumin 1% in PBS. Incubation with the pri-
mary antibody was carried out overnight at 4◦C( a n t i l e p t i n
receptor 1/250). Grids were washed with PBS and incubated
on 1% ovalbumin prior to the 30-minute incubation with
the protein A-gold complex (10nm). They were then washed
with PBS and distilled water. Counterstaining was obtained
with uranyl acetate. Control experiments were carried out
in parallel by omitting the primary antibody from the
labeling protocol. Cells were then examined with a Philips
410LSelectronmicroscope(FEISystemsCanada;St-Laurent,
Canada).
2.10. Statistical Analysis. Student t-tests were used to com-
pare control and assay conditions. Results were expressed as
mean ± SEM.
3. Results
3.1. Caco-2/15 Cell Monolayer as a Model for the Study of
Leptin Transcytosis. The Caco-2/15 intestinal cell monolayer
culture demonstrates several characteristics of intestinal
epithelial cells and is being widely used as a model [24].
Tightness of the monolayer was conﬁrmed by measuring
electric resistance (>600ohms) and by light and electron
microscopic examination of the monolayer itself and of
the tight junctional complexes in particular (Figure 1(a))
[24]. By immunoblot, freshly formed leptin-FITC complex
is recognized as a single band of 16kDa by antibodies
against leptin and against FITC (Figure 1(b)). Once well
characterized, it was carefully added to the apical medium
of cultures at a ﬁnal concentration of 10μg/mL. The
basal medium was sampled at times 0, 15, 30, and 60
minutes and cells homogeneized at 60 minutes. For each
immunoblotting, a reference curve using 0.1, 0.5, 1, and
2ng/mL of leptin was carried out to be able to quantify the
leptin band density. The reference curve was found to be
linear up to 1ng/mL (Figure 1(c)). Appearance of leptin-
FITC in the basal medium was evaluated as a function of
time (Figure 1(d)). Leptin in the basal medium appeared
in a linear fashion during the ﬁrst 30 minutes with a
maximal concentration at 14ng/mL. Leptin cell content
was measured at the end of the experiment (Figure 1(e)).4 International Journal of Cell Biology
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Figure 1: Transcytosis of leptin through Caco-2/15 cell monolayer. (a) Intestinal caco 2/15 cells grow as a tight polarized monolayer displaying
apical microvillosities (mv) and tight junctional complexes (J). (b) Upon preparation of the leptin-FITC complex, leptin is revealed by
Western blot as a single band of 16kDa using antibodies against leptin as well as against FITC. (c) Quantiﬁcation of leptin by Western blot
is linear up to 1ng/mL. (d) Leptin-FITC (10μg/mL) added to the apical compartment of Caco-2/15 cell monolayer is transported to the
basal compartment along with time and appears to be saturable. (e) Leptin intracellular content was raised signiﬁcantly at the end of the
experiment (60 minutes). Results are expressed as mean values ± s.e.m (n = 4 for each experiments).International Journal of Cell Biology 5
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Figure 2: Eﬀect of temperature on leptin transcytosis. Leptin-FITC (10μg/mL) was added to the apical compartment of Caco-2/15 cell
monolayer which was kept either at 4◦Co r3 7
◦C. Leptin concentration in the basal compartment was measured at 0, 30, and 60 minutes for
both conditions. (a) Incubation at 4◦C inhibits the transport of leptin to the basal compartment at all time points. (b) Leptin intracellular
contents after 60 minutes of incubation showed a 85% decrease at 4◦C as compared to 37
◦C. Bars represent mean values ± s.e.m (n = 4).
Leptin content increased from 0 to 81ng/mg protein in 60
minutes. The same experiment carried out at 4◦Cr e s u l t e d
in the total absence of leptin-FITC in the basal medium
(Figure 2(a)) while intracellular leptin content was severely
reduced (−85% compared to 37
◦C) (Figure 2(b)).
3.2. Role of Membrane-Bound Leptin Receptors in the Tran-
scytosis of Leptin. Caco-2/15 cells express mRNA for the
long (219.1) and the short (219.3) isoforms of the leptin
receptor (Figure 3(a)), while short isoform 219.2 was not
detected. The presence of the long (120KDa) and short
(90KDa) isoforms as well as the soluble isoform (80kDa) for
leptin receptor was conﬁrmed by immunoblot (Figure 3(b)).
Confocal immunohistochemical microscopy carried out
on Caco 2/15 cells revealed strong labellings for leptin
receptor at the apical region of the cells (Figure 3(c1))
while the signal deeper inside the same cells was of lower
intensity (Figure 3(c2)). These results were conﬁrmed by
immunogold electron microscopy, which demonstrated that
leptin receptors are indeed expressed on the apical plasma
membrane of the Caco-2/15 cells particularly at the level
of the microvilli (Figure 3(d1)) and on the baso-lateral
membrane (not illustrated). They were also found on the
membrane of some endocytotic vesicles (e) (Figure 3(d1)).
Control for the immunocytochemical experiments resulted
inanabsenceoflabellingandveryfewscatteredgoldparticles
on the apical region of cells, indicating a good speciﬁcity of
the labellings (Figure 3(d2)).
To assess whether these receptors are involved in leptin
transcytosis, Caco-2/15 cells were infected with lentiviruses
containing a speciﬁc short hairpin RNA (shRNA). Construct
C7 codes a shRNA that recognizes a sequence speciﬁc to the
intracellular domain of the long receptor isoform 219.1. C9
shRNA is complementary to a sequence of mRNA common
to both receptors 219.1 and 219.3. The pLKO.1 virus was
generated with the empty plasmid and is used as a control.
Successful invalidation of the leptin receptors was conﬁrmed
by RT-PCR (Figure 4(a)) and Western blot (Figure 4(b)).
Infection with plasmid C7 led to a 48% decrease of the long
isoform of the receptor (219.1) with no signiﬁcant changes
for the short isoform (219.3) (Figure 4(c1)). Plasmid C9
decreased the long (219.1) and the short (219.3) isoforms by
47% and 45%, respectively (Figure 4(d1)).
Transcytosis experiments carried out on plasmid C7-
infected cells revealed that leptin intracellular contents and
leptin transferred to the basal medium were reduced by 43%
and 58%, respectively (Figure 4(c2)). Transcytosis by plas-
mid C9-infected cells was decreased by 57% for intracellular
leptinandby68%forbasalleptin(Figure 4(d2)).Diﬀerences
in results obtained with C7 and C9 cells were not statistically
diﬀerent.
3.3. Presence of Leptin Soluble Receptor in the Basal Medium
of Caco-2/15 Cell Culture. We examined whether Caco-2/15
cells released the soluble isoform of the receptor complexed
to leptin in the basal medium. To this end, leptin was
added in the upper medium of the Caco-2/15 cell monolayer
and upon 60 minutes of incubation, proteins of the basal
medium were assessed by Western blot. A single band at
80kDa was recognized by the antibody directed against
the leptin receptor (Figure 5(a))[ 9, 25]. Furthermore, after
immunoprecipitation with the antireceptor antibody, the
80kDa protein was found to be complexed to a protein of
16kDa, recognized by the antileptin antibody (Figure 5(b)).
Immunoprecipitation using the leptin antibody yielded the
same two bands, one at 16 and one at 80kDa (Figure 5(b)).6 International Journal of Cell Biology
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Figure 3: Presence of leptin receptors in Caco-2/15 cells. (a) Leptin receptor long (219.1) and short (219.3) isoform mRNAs are present in
Caco-2/15 cells as revealed by RT-PCR analysis. (b) In three diﬀerent experiments (C1, C2, C3), Western blots demonstrate the presence
of the long (219.1) (120kDa) and short (219.3) (100kDa) isoforms of the leptin receptor, as well as that of the soluble receptor (OBRs)
(80kDa). The isoform 219.2 was not found. Confocal microscopy carried out on cell monolayer displays intense green staining for the leptin
receptor on the apical pole of the cells (c1) and a more granulated and dispersed staining on more central regions of the same cells (c2). (d1)
Immunogold electron microscopy conﬁrms the presence of the leptin receptor on the apical plasma membrane particularly at the level of the
microvilli (mv) and on the limiting membrane of endocytotic vesicles where gold particles are easily detected (e). (d2) Control of speciﬁcity:
cell monolayers were incubated without the primary antibody showing absence of labelling by gold particles.International Journal of Cell Biology 7
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Figure 4: Transcytosis of leptin in knockdown cells. Cells were infected with lentiviruses containing plKO.1, C7, or C9 shRNA. Leptin was
added to the apical medium of C7 and C9 infected cells and leptin intracellular content (I-Lep) as well as leptin concentrations in the basal
medium (B-Lep) were assessed. Results of the invalidations on the long (219.1) and short (219.3) isoforms were analyzed by RT-PCR (a) and
Western blot (b). (c) Infection with the C7-virus decreased expression of the long isoform (−48%) (c1) without aﬀecting signiﬁcantly the
short one, and decreased I-Lep (−43%) and B-Lep (−58%) (c2). (d) C9-virus decreased both long and short isoforms, respectively by 47%
and 45% (d1), and decreased I-Lep (−57%) and B-Lep (−68%) (d2). Bars represent the mean value ± s.e.m of 6 independent experiments.
To further evaluate the secretion of this soluble leptin
receptor, intensities of the 80kDa band in the basal media
from plKO.1-, C7-, and C9-infected cells were compared.
The signals were decreased 22% for C7 and 55% for C9
when compared to control pLKO.1 (Figure 5(c)). Similar
measurements on infected-cell homogenates revealed a 33%
and 60% decrease of intracellular soluble leptin receptor by
C7 and C9, respectively (Figure 5(d)).
3.4. Endocytotic Pathway of Leptin. Caco-2/15 cells were
preincubated for 30 minutes with compounds that were
reported to be endocytosis inhibitors, namely, chlorproma-
zine which among other actions inhibits clathrin-dependent
endocytosis, nystatin that inhibits clathrin-independent
endocytosis,andamiloridetoblockmacropinocytosis. Upon
preincubation, leptin was added to the upper medium for
30 minutes and intracellular leptin was assessed. Amiloride8 International Journal of Cell Biology
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Figure 5: Presence of the soluble leptin receptor (OBRs) in the basal compartment of Caco-2/15 cell culture. (a) Detection of the soluble leptin
receptor (OBRs) by immunoblot was carried out on the basal medium of 3 diﬀerent experiments. (b) Immunoprecipitation of the media
using the antibody against leptin receptor reveals the presence of the soluble receptor (80kDa) associated to leptin (16kDa); inversely,
immunoprecipitation with the leptin antibody led to the same bands. Levels of soluble leptin receptor were measured in supranatant culture
media (c) and in homogenates (d) from cells infected with pLKO.1, C7 or C9 virus. OBRs levels in basal media and cell homogenates were
signiﬁcantly decreased by C7 or C9. Bars represent the mean values ± s.e.m (n = 5).
(3mM) and nystatin (25μg/mL) had no signiﬁcant eﬀect
on leptin uptake while chlorpromazine (6μg/mL) decreased
leptin intracellular content by 57% (Figure 6(a)). To further
characterize this inhibition, cells were incubated with leptin
and analyzed at shorter time (2, 5, and 10 minutes)
(Figure 6(b)). Chlorpromazine was eﬀective at all times,
indicating that its eﬀect is not mediated by an increase
in leptin recycling. Also, two additional experiments were
carried out. Insulin which is known to be internalized in
a clathrin-dependent fashion [26] and albumin (clathrin
independent absorption) [27] were tested. In the presence of
chlorpromazine, insulin internalization was reduced to the
same extent as leptin (42%), while albumin was only lightly
aﬀected by 11% (results not shown).
Since we previously demonstrated in in vivo studies that
leptinischannelledthroughtheGolgiapparatusinduodenal
epithelial cells, we wanted to determine whether passage
through the Golgi apparatus also represents a signiﬁcant
step along leptin transcytosis through Caco-2/15 cells.
Immunocytochemistry was carried out on cells incubated
for 30 minutes with leptin-FITC. Labelling for leptin-FITC
revealed a positive signal within the cell cytoplasm in the
form of small vesicular proﬁles particularly evident close to
the nuclei (XY plane, Figure 7(a)). Staining for a marker of
the trans-Golgi network (TGN42) led to a red perinuclear
signal that partially colocalized (yellow spots) with the leptin
green signal, indicating the presence of internalized leptin
in the trans-Golgi compartment (XY plane, Figure 7(a)).
Quantiﬁcation of the staining intensity for leptin and
TGN42 on the XZ plane conﬁrmed their colocalization
(Figure 7(b)). To further demonstrate the involvement of
the Golgi apparatus in the transfert of leptin, Caco-2/15
cells were preincubated for 30 minutes with brefeldin A
(10μg/mL) or okadaic acid (0.5μM) prior to leptin addition.
These agents are known to break down the Golgi apparatus
and alter Golgi traﬃcking. Brefeldin A leads to the fusion of
Golgi cisternae and rough endoplasmic reticulum, eﬃciently
blocking protein traﬃcking [28] while okadaic acid induces
fragmentation of the Golgi apparatus [29]. Endocytosis and
transcytosis of leptin under these conditions were decreasedInternational Journal of Cell Biology 9
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Figure 6: Inhibition of leptin endocytosis. Caco-2/15 cells were preincubated with the following inhibitors of endocytosis: Amiloride (Amil)
(3mM), chlorpromazine (Chlor) (6μg/mL), and nystatin (Nyst) (25μg/mL). Leptin was added to the apical medium for 30 minutes and
intracellular leptin contents were measured. (a) A signiﬁcant decrease was observed only with chlorpromazine treatment. (b) Speciﬁcity
of chlorpromazine treatment was conﬁrmed by measuring of intracellular leptin at shorter incubation times (2, 5, and 10 minutes). Mean
values ± s.e.m (n = 4).
by 70% and 54%, respectively for brefeldin A, and 84% and
76% for okadaic acid, when compared to their respective
controls (Figure 7(c)).
4. Discussion
The present study reveals the transcytotic transport of leptin
across the polarized Caco-2/15 cells and highlights some of
the characteristics of this transport. Leptin exposed to the
apical side of the cells is internalized and transferred to the
basolateral pole to be secreted into the basal medium though
a transcytotic mechanism. We found that the long isoform
of the leptin receptor is required in order to carry out what
appears to be a clathrin-mediated endocytosis of the leptin
present in the apical medium. We also show that the Golgi
apparatus is involved in this intracellular transit of leptin.
Leptin is eventually released into the basal medium bound
to its soluble receptor.
We have previously reported that leptin secreted by the
gastric mucosa into the gastric juice in vivo and vehiculated
to the duodenal lumen is captured by the intestinal mucosa,
internalized, transcytosed, and secreted to be delivered into
the systemic circulation [16]. Herein, we attempt to decipher
certain aspects of this transport using the in vitro Caco-2/15
cell line, an eﬃcient model of human intestinal cells [24].
Caco-2/15cellsweregrowntoconﬂuencyconstitutingatight
polarized and well-diﬀerentiated monolayer of epithelial
cells as demonstrated by light and electron microscopy10 International Journal of Cell Biology
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Figure 7: Involvement of the Golgi apparatus in leptin transcytosis. Caco-2 cells were exposed to leptin-FITC for 30 minutes. (a) By confocal
microscopy, leptin (green ﬂuorescence) and TGN42, a marker of the Golgi apparatus (red ﬂuorescence), appear colocalized (yellow staining)
in spots (XZplane) or as crescent-shaped structures close to the nuclei (XY plane). (b) Quantiﬁcation of signal for leptin and TGN42 in XZ
view conﬁrmed colocalization. (c) Inhibitors of Golgi traﬃcking, brefeldin A (Bref) (10μg/mL), and okadaic acid (Okad.a) (0.5μM) were
added to the cell medium for 30 minutes prior adding leptin. Cellular content (c1) and concentrations of leptin in the basal medium (c2)
were decreased by the two agents. Results are expressed as mean values ± s.e.m (n = 4).International Journal of Cell Biology 11
[24] and by the apical expression of villin and sucrase
isomaltase [30]. The monolayer delimits tight upper and
lower compartments, a very suitable in vitro model to
study transepithelial transport [2, 31]. The tightness of the
monolayer is supported by the high electric resistance of
the culture monolayer and the presence of well-developed
junctional complexes.
We have demonstrated that leptin introduced in the
mediumoftheuppercompartmentofthecellculturecrosses
the cell monolayer to reach the lower compartment, in a
time- and temperature-dependent and saturable manner,
suggesting the involvement of a speciﬁc transporter, as
reported for other proteins [19, 31]. At 37
◦C, intracel-
lular content of leptin rapidly increases; however, it was
potently inhibited at 4◦C( −85%), which reﬂects an energy-
dependent mechanism. Transport through a paracellular
pathway was excluded, as shown by the complete absence of
leptin in the lower compartment in cold conditions (4◦C).
Receptor-mediated transcytosis is a well-established sys-
tem for protein transport [32]. Studies on endothelial cells
have demonstrated that leptin receptors participate in the
transcytotic transport of leptin through the blood brain
barrier [13, 33] and that both the short and the long
isoforms of the receptor carry leptin with the same eﬃciency
[12]. In the present study, we observed that Caco-2/15 cells
also express the long (219.1) and short (219.3) isoforms
of the leptin receptor, which conﬁrms previous reports on
intestinal human tissues and Caco-2/15 cell line [34–36]a n d
these receptors are present on the apical portion of the cells
at the level of the microvilli.
Knocking-down the long isoform was eﬀective in
decreasing both endocytosis and transcytosis of apical leptin.
On the other hand, the invalidation of both the short and
long isoforms had no cumulative eﬀect, suggesting that the
long isoform is mostly responsible for the transport of leptin
through Caco-2/15 cell monolayer. These results diﬀer from
the situation reported in endothelial cells, where the short
isoform of the leptin receptor seems to be the main carrier
[13]. However, in endothelial cells, the short isoform of the
receptor represents 80% of all leptin receptors while for
Caco-2/15 cells the long isoform of the receptor is the one
to be highly expressed [13]. It must also be noted that, in
renal epithelial cells, the short isoform of the receptor is the
one to target the lysosomal compartment more eﬃciently
than the long one, which indicates that the long isoform
could be more involved in nondegradative intracellular and
transcellular pathways [12].
In blood and in gastric juice, leptin circulates bound
to a protective protein which is the soluble isoform of its
receptor [9]. This soluble isoform of the receptor arises from
the proteolytic cleavage of the membrane-bound one [37].
We found that leptin released in the basal compartment by
Caco-2/15 cells is indeed complexed to this soluble receptor.
The leptin complex found in the basal medium is formed by
leptin and a protein recognized by the antibody against the
extracellular portion of the leptin receptor which displays
the expected molecular mass of the human soluble leptin
receptor (80kDa) [9, 25, 38]. Finally, the presence of the
complex leptin-soluble receptor intracellularly and in the
basal medium was decreased following the knockdown of
leptin receptors. Our observations corroborate the origin of
the soluble receptor as derived from long and short receptor
isoforms by proteolytic cleavage [37]. Thus, the in vitro
situation appears to mimic the in vivo one in which leptin
is not secreted and does not circulate free but rather in the
form of a complex bound to its soluble receptor in the blood
as well as in the gastric juice [9].
The mechanism of leptin uptake was unravelled by
the use of inhibitors of endocytosis. Chlorpromazin which
among other eﬀects is a clathrin-mediated endocytosis
inhibitor inducing redistribution of AP-2 to endosomes
[39];nystatinisacholesterol-sequestratingdrugthatinhibits
clathrin independent endocytosis without aﬀecting clathrin-
dependent one [40], while amiloride prevents macropinocy-
tosis [41]. In our conditions, only chlorpromazine was
eﬀective in blocking leptin uptake. Clathrin is expressed on
theapicalmembraneofCaco-2/15cellsandisinvolvedinthe
transport of transferrin [42, 43]. Furthermore, endocytosis
of leptin receptors, both the long and short isoforms, is
dependent on clathrin vesicles in several cell types [12,
44]. Caco-2/15 cells seem therefore to follow the classic
clathrin-dependent pathway for leptin receptor endocytosis
[45].
DuringtranscytosisthroughCaco-2/15cells,internalized
leptinwasfoundincisternaeoftheGolgiapparatus,similarly
to observations made in situ on duodenal tissue [16].
Involvement of the Golgi apparatus in the transcytotic
pathway may be required for the formation of the complex
leptin-soluble receptor found in the basal medium. Leptin,
endocytosed as a free protein at the apical membrane of
Caco-2/15 cells, travels to the Golgi apparatus where it must
bind to newly synthesized receptor molecules prior to its
releaseinthebasalmedium.Thisensuresprotectionofleptin
in the basal medium as it occurs in vivo. Disruption of the
Golgi apparatus by brefeldin A or okadaic acid decreased
the appearance of the leptin-receptor complex in the basal
medium. Several hypotheses may explain our observations.
It has been reported that in Hela cells, newly synthesized
short and long isoforms of leptin receptor are mostly stored
in the trans-Golgi network, with low expression at the
plasma membrane [46]. On the other hand, constitutive
endocytosis in ligand-independent manner occurs for leptin
receptorwithtransporttolysosomes,withalimitedrecycling
to the cell surface [46]. In Hela-cells, 40% of both leptin
receptor isoforms are internalized within 15 minutes. We can
presume that in the presence of Golgi traﬃcking inhibitors,
constitutive endocytosis in Caco-2/15 cells may suﬀer a
severe depletion in leptin receptors at the plasma membrane,
thereby limiting leptin uptake. On the other hand, okadaic
acid that increased caveolae-dependent endocytosis, also
decreases the clathrin one, which may explain the decreased
endocytosis observed in our conditions [47].
In conclusion, we have shown that leptin follows a
transcytotic pathway which includes clathrin-dependent
endocytosis mediated by its membrane-bound receptors.
After passage through the Golgi apparatus, leptin is released
in the basal medium in a complex form bound to the soluble
form of its receptor.12 International Journal of Cell Biology
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